Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era
Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era作者机构:School of Dentistry The University of Queensland Centre for Orofacial Regeneration Reconstruction and Rehabilitation (COR3) School of Dentistry The University of Queensland Australian Institute for Bioengineering and Nanotechnology The University of Queensland Terasaki Institute for Biomedical Innovation
出 版 物:《National Science Review》 (国家科学评论(英文版))
年 卷 期:2022年第9卷第10期
页 面:230-242页
核心收录:
学科分类:0831[工学-生物医学工程(可授工学、理学、医学学位)] 0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 08[工学] 0805[工学-材料科学与工程(可授工学、理学学位)]
基 金:supported by an Early Career Fellowship from the National Health and Medical Research Council of Australia a UQ Amplify Fellowship from The University of Queensland
主 题:COVID-19 SARS-CoV-2 diagnosis nanotechnology vaccines
摘 要:Following the global COVID-19 pandemic,nanotechnology has been at the forefront of research efforts and enables the fast development of diagnostic tools,vaccines and antiviral treatment for this novel virus(SARS-CoV-2).In this review,we first summarize nanotechnology with regard to the detection of SARS-C oV-2,including nanoparticle-based techniques such as rapid antigen testing,and nanopore-based se quencing and sensing techniques.Then we investigate nanote chnology as it applies to the development of COVID-19 vaccines and anti-SARS-CoV-2 nanomaterials.We also highlight nanotechnology for the post-pandemic era,by providing tools for the battle with SARS-C oV-2 variants and for enhancing the global distribution of vaccines.Nanotechnology not only contributes to the management of the ongoing COVID-19 pandemic but also provides platforms for the prevention,rapid diagnosis,vaccines and antiviral drugs of possible future virus outbreaks.